• Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
La Jolla Institute for Immunology
  • About Us
    • Overview
      • History
      • President’s Message
      • Institute Facts
    • Our Team
      • Leadership
      • Faculty
        • Emeriti
        • LJI Scholars
        • Clinical Associates
      • Board of Directors
      • Scientific Advisory Board
    • Statements
      • LJI Diversity and Inclusion Statement
      • Vaccines
  • Labs
    • Altman Lab
    • Ay Lab
    • Benedict Lab
    • Cheroutre Lab
    • Croft Lab
    • Crotty Lab
    • Hedrick Lab
    • Hogan Lab
    • Kawakami Lab
    • Kronenberg Lab
    • Ley Lab
    • Peters Lab
    • Rao Lab
    • Saphire Lab
    • Schoenberger Lab
    • Sette Lab
    • Sharma Lab
    • Shresta Lab
    • Vijayanand Lab
    • von Herrath Lab
  • Research
    • Overview
    • COVID-19
    • Diseases (A-Z)
    • Research Centers
      • Center for Autoimmunity and Inflammation
      • Center for Cancer Immunotherapy
      • Center for Infectious Disease and Vaccine Research
    • Database of Immune Cell Epigenomics
    • Immune Epitope Database
    • Translational Research
    • Technology Development
    • Research Services
      • Bioinformatics
      • Clinical Studies
      • Cryo-EM
      • DLAC
      • Flow Cytometry
      • Microscopy & Histology
      • Next Generation Sequencing
    • Publications
  • News
    • Latest News
    • Media Inquiries
  • Seminars
    • Seminars
    • Life Without Disease Seminar Series
  • Immune Matters
  • Support
    • Overview
    • Giving Opportunities
      • The Tullie and Rickey Families SPARK Program
      • Center for Precision Immunotherapy
      • SURGE Program
      • Together for Asthma
    • Ways to Give
    • Vanguard Giving Society
    • Planned Giving
    • CARES Act
    • Advancement Team
    • Clinical Studies
    • DONATE
  • Careers
    • Open Positions
    • Postdoctoral Training
    • Postdoctoral Association
    • Internships
  • Contact
Support

Publications

Reset
Jan 6, 2021 Science
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, Grifoni A, Ramirez SI, Haupt S, Frazier A, Nakao C, Rayaprolu V, Rawlings SA, Peters B, Krammer F, Simon V, Saphire EO, Smith DM, Weiskopf D, Sette A, Crotty S.
Oct 1, 2020 Cell
Lifted Up from Lockdown
Arturo EC, Saphire EO
Aug 20, 2020 Cell
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, Hastie KM, Parker MD, Partridge DG, Evans CM, Freeman TM, de Silva TI; Sheffield COVID-19 Genomics Group, McDanal C, Perez LG, Tang H, Moon-Walker A, Whelan SP, LaBranche CC, Saphire EO, Montefiori DC.
Apr 2, 2020 Cell
A Vaccine against Ebola Virus
Saphire EO
Feb 18, 2020 Immunity
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Gilchuk P, Murin CD, Milligan JC, Cross RW, Mire CE, Ilinykh A, Huang K, Kuzmina N, Altman PX, Hui S, Gunn BM, Bryan AL, Davidson E, Doranz BJ, Turner HL, Alkutkar T, Flinko R, Orlandi C, Carnahan R, Nargi R, Bombardi RG, Vodzak ME, Li S, Okoli A, Ibeawuchi M, Ohiaeri B, Lewis GK, Alter G, Bukreyev A, Saphire EO, Geisbert TW, Ward AB, Crowe JE Jr
Jan 15, 2020 Viruses
Reporter Assays for Ebola Virus Nucleoprotein Oligomerization, Virion-Like Particle Budding, and Minigenome Activity Reveal the Importance of Nucleoprotein Amino Acid Position 111
Lin AE, Diehl WE, Cai Y, Finch CL, Akusobi C, Kirchdoerfer RN, Bollinger L, Schaffner SF, Brown EA, Saphire EO, Andersen KG, Kuhn JH, Luban J, Sabeti PC
Sep 16, 2019 Viruses
Diverse morphology and structural features of old and new world hantaviruses
Parvate A, Williams EP, Taylor MK, Chu YK, Lanman J, Saphire EO, Jonsson CB
Aug 8, 2019 Cell
Convergent structures illuminate features for germline antibody binding and pan-Lassa virus neutralization
Hastie KM, Cross RW, Harkins SS, Zandonatti MA, Koval AP, Heinrich ML, Rowland MM, Robinson JE, Geisbert TW, Garry RF, Branco LM, Saphire EO
Aug 1, 2019 Curr Opin Virol
Antibody therapy for Lassa fever
Cross RW, Hastie KM, Mire CE, Robinson JE, Geisbert TW, Branco LM, Ollmann Saphire E, Garry RF
Jul 23, 2019 MBio
Sudan ebolavirus VP35-NP crystal structure reveals a potential target for pan-filovirus treatment
Landeras-Bueno S, Oda SI, Norris MJ, Li Salie Z, Guenaga J, Wyatt RT, Saphire EO
May 30, 2019 Cell
Longitudinal analysis of the human B cell response to ebola virus infection
Davis CW, Jackson KJL, McElroy AK, Halfmann P, Huang J, Chennareddy C, Piper AE, Leung Y, Albarino CG, Crozier I, Ellebedy AH, Sidney J, Sette A, Yu T, Nielsen SCA, Coff AJ, Spiropoulou CF, Saphire EO, Cavet G, Kawaoka Y, Mehta AK, Glass PJ, Boyd SD, Ahmed R
Apr 7, 2019 Nat Commun
Cross-reactive neutraliing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk
King LB, West BR, Moyer CL, Gilchuk P, Flyak A, Ilinykh PA, Bombardi R, Hui S, Huang K, Bukreyev A, Crowe JE Jr, Saphire EO
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • 9
  • 10
  • Contact Us
  • Careers
  • Terms & Conditions
  • Privacy Policy
La Jolla Institute for Immunology

contact@lji.org
9420 Athena Circle
La Jolla, CA 92037

Phone: +1 (858) 752-6500

© 2020 La Jolla Institute for Immunology. All rights reserved.LJI is a 501(c)3 tax-exempt organization.Federal Tax ID Number 33-0328688

Designed and Developed by Creative Science Labs

Location:
We use cookies to analyze site traffic and to ensure that we give you the best experience on our website. We do not sell data obtained through the use of cookies. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.OkPrivacy policy